Residual apoptotic activity of a tumorigenic p53 mutant improves cancer therapy responses
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Residual apoptotic activity of a tumorigenic p53 mutant improves cancer therapy responses ; volume:38 ; number:20 ; year:2019 ; extent:23
The EMBO journal / European Molecular Biology Organization ; 38, Heft 20 (2019) (gesamt 23)
- Urheber
-
Timofeev, Oleg
Klimovich, Boris
Schneikert, Jean
Wanzel, Michael
Pavlakis, Evangelos
Noll, Julia
Mutlu, Samet
Elmshäuser, Sabrina
Nist, Andrea
Mernberger, Marco
Lamp, Boris
Wenig, Ulrich
Brobeil, Alexander
Gattenlöhner, Stefan
Köhler, Kernt
Stiewe, Thorsten
- DOI
-
10.15252/embj.2019102096
- URN
-
urn:nbn:de:101:1-2022081206551970588768
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Timofeev, Oleg
- Klimovich, Boris
- Schneikert, Jean
- Wanzel, Michael
- Pavlakis, Evangelos
- Noll, Julia
- Mutlu, Samet
- Elmshäuser, Sabrina
- Nist, Andrea
- Mernberger, Marco
- Lamp, Boris
- Wenig, Ulrich
- Brobeil, Alexander
- Gattenlöhner, Stefan
- Köhler, Kernt
- Stiewe, Thorsten
Ähnliche Objekte (12)
NUAK2 and RCan2 participate in the p53 mutant pro-tumorigenic network
NUAK2 and RCan2 participate in the p53 mutant pro-tumorigenic network
The antagonism between MCT-1 and p53 affects the tumorigenic outcomes
HIPK2 modulates p53 activity towards pro-apoptotic transcription
How mutant p53 empowers Foxh1 fostering leukaemogenesis?
How mutant p53 empowers Foxh1 fostering leukaemogenesis?
Targeting mutant p53 in cancer: the latest insights
Id4 dependent acetylation restores mutant-p53 transcriptional activity
Exploring mutant p53 targeting strategies for cancer therapy
Therapeutic targeting of BRCA1 and TP53 mutant breast cancer through mutant p53 reactivation
TAF6δ orchestrates an apoptotic transcriptome profile and interacts functionally with p53
Glycerol restores heat-induced p53-dependent apoptosis of human glioblastoma cells bearing mutant p53
NUAK2 and RCan2 participate in the p53 mutant pro-tumorigenic network
NUAK2 and RCan2 participate in the p53 mutant pro-tumorigenic network
The antagonism between MCT-1 and p53 affects the tumorigenic outcomes
HIPK2 modulates p53 activity towards pro-apoptotic transcription
How mutant p53 empowers Foxh1 fostering leukaemogenesis?
How mutant p53 empowers Foxh1 fostering leukaemogenesis?
Targeting mutant p53 in cancer: the latest insights
Id4 dependent acetylation restores mutant-p53 transcriptional activity
Exploring mutant p53 targeting strategies for cancer therapy
Therapeutic targeting of BRCA1 and TP53 mutant breast cancer through mutant p53 reactivation
TAF6δ orchestrates an apoptotic transcriptome profile and interacts functionally with p53
Glycerol restores heat-induced p53-dependent apoptosis of human glioblastoma cells bearing mutant p53
NUAK2 and RCan2 participate in the p53 mutant pro-tumorigenic network
NUAK2 and RCan2 participate in the p53 mutant pro-tumorigenic network
The antagonism between MCT-1 and p53 affects the tumorigenic outcomes
HIPK2 modulates p53 activity towards pro-apoptotic transcription
How mutant p53 empowers Foxh1 fostering leukaemogenesis?
How mutant p53 empowers Foxh1 fostering leukaemogenesis?
Targeting mutant p53 in cancer: the latest insights
Id4 dependent acetylation restores mutant-p53 transcriptional activity
Exploring mutant p53 targeting strategies for cancer therapy
Therapeutic targeting of BRCA1 and TP53 mutant breast cancer through mutant p53 reactivation
TAF6δ orchestrates an apoptotic transcriptome profile and interacts functionally with p53